Hammersmith Hospital

The group from Imperial College London's Hammersmith Hospital has developed a duplex qPCR assay that measures both BCR-ABL1 target and endogenous control transcripts in the same reaction with no loss of sensitivity compared to a previously used simplex test.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.